Gilead Sciences

Gilead Sciences as of Dec. 31, 2024

Portfolio Holdings for Gilead Sciences

Gilead Sciences holds 16 positions in its portfolio as reported in the December 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Arcellx Common Stock (ACLX) 33.2 $515M 6.7M 76.69
Galapagos Nv Spon Adr (GLPG) 29.8 $462M 17M 27.64
Arcus Biosciences Incorporated (RCUS) 28.9 $448M 30M 14.89
Assembly Biosciences Com New (ASMB) 2.2 $35M 2.2M 15.78
Merus N V (MRUS) 1.2 $19M 453k 42.05
Kyverna Therapeutics (KYTX) 1.0 $15M 4.1M 3.74
Leap Therapeutics Com New (LPTX) 1.0 $15M 5.3M 2.88
Tango Therapeutics (TNGX) 1.0 $15M 4.9M 3.09
Xilio Therapeutics (XLO) 0.6 $8.7M 9.1M 0.95
Allovir (ALVR) 0.5 $7.0M 17M 0.42
Hookipa Pharma Com New (HOOK) 0.2 $3.8M 1.9M 2.01
Ikena Oncology (IKNA) 0.2 $3.3M 2.0M 1.64
Allogene Therapeutics (ALLO) 0.2 $2.5M 1.2M 2.13
Barinthus Biotherapeutics Pl Ads (BRNS) 0.0 $749k 620k 1.21
Agenus Com New (AGEN) 0.0 $635k 232k 2.74
Kronos Bio 0.0 $179k 189k 0.95